Thomas Sweeney Heard

Array ( [id] => 8875805 [patent_doc_number] => 08470771 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-25 [patent_title] => 'Method and medicament for inhibiting the infection of influenza virus' [patent_app_type] => utility [patent_app_number] => 12/743028 [patent_app_country] => US [patent_app_date] => 2007-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 16 [patent_no_of_words] => 15266 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12743028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9964792 [patent_doc_number] => 09012404 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-21 [patent_title] => 'Compositions and methods for cardiac tissue protection and regeneration' [patent_app_type] => utility [patent_app_number] => 12/518624 [patent_app_country] => US [patent_app_date] => 2007-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9857 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12518624 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4476084 [patent_doc_number] => 07868136 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-11 [patent_title] => 'Search for cancer markers by a screening method' [patent_app_type] => utility [patent_app_number] => 11/987983 [patent_app_country] => US [patent_app_date] => 2007-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 11081 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/868/07868136.pdf [firstpage_image] =>[orig_patent_app_number] => 11987983 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9239187 [patent_doc_number] => 08603978 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-10 [patent_title] => 'Use of muramyl dipeptide (MDP) for treating inflammation' [patent_app_type] => utility [patent_app_number] => 12/516633 [patent_app_country] => US [patent_app_date] => 2007-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 79 [patent_no_of_words] => 18519 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12516633 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6602972 [patent_doc_number] => 20100062987 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'ANTICONVULSIVE PHARMACEUTICAL COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 12/515792 [patent_app_country] => US [patent_app_date] => 2007-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6440 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20100062987.pdf [firstpage_image] =>[orig_patent_app_number] => 12515792 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7530449 [patent_doc_number] => 07842671 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-11-30 [patent_title] => 'Peptidomimetic inhibitors of STAT activity and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/986237 [patent_app_country] => US [patent_app_date] => 2007-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 14 [patent_no_of_words] => 9076 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/842/07842671.pdf [firstpage_image] =>[orig_patent_app_number] => 11986237 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4727980 [patent_doc_number] => 20080207524 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'MEDICINAL PREPARATIONS FOR TREATING SEX HORMONE-DEPENDENT DISEASES' [patent_app_type] => utility [patent_app_number] => 11/941356 [patent_app_country] => US [patent_app_date] => 2007-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11750 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20080207524.pdf [firstpage_image] =>[orig_patent_app_number] => 11941356 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5290922 [patent_doc_number] => 20090023652 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-22 [patent_title] => 'POLYCATIONIC CALCIUM MODULATOR PEPTIDES FOR THE TREATMENT OF HYPERPARATHYROIDISM AND HYPERCALCEMIC DISORDERS' [patent_app_type] => utility [patent_app_number] => 11/941857 [patent_app_country] => US [patent_app_date] => 2007-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 21234 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20090023652.pdf [firstpage_image] =>[orig_patent_app_number] => 11941857 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4751909 [patent_doc_number] => 20080159982 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-03 [patent_title] => 'HEPATITIS C VIRUS INHIBITORS' [patent_app_type] => utility [patent_app_number] => 11/939753 [patent_app_country] => US [patent_app_date] => 2007-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34266 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20080159982.pdf [firstpage_image] =>[orig_patent_app_number] => 11939753 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4866275 [patent_doc_number] => 20080145334 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-19 [patent_title] => 'HEPATITIS C VIRUS INHIBITORS' [patent_app_type] => utility [patent_app_number] => 11/939768 [patent_app_country] => US [patent_app_date] => 2007-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34928 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0145/20080145334.pdf [firstpage_image] =>[orig_patent_app_number] => 11939768 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4535681 [patent_doc_number] => 07888464 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-15 [patent_title] => 'Hepatitis C virus inhibitors' [patent_app_type] => utility [patent_app_number] => 11/939780 [patent_app_country] => US [patent_app_date] => 2007-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42634 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/888/07888464.pdf [firstpage_image] =>[orig_patent_app_number] => 11939780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4922569 [patent_doc_number] => 20080070885 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-20 [patent_title] => 'MACROCYCLIC COMPOUNDS HAVING ASPARTIC PROTEASE INHIBITING ACTIVITY AND PHARMACEUTICAL USES THEREOF' [patent_app_type] => utility [patent_app_number] => 11/939936 [patent_app_country] => US [patent_app_date] => 2007-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11332 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20080070885.pdf [firstpage_image] =>[orig_patent_app_number] => 11939936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6306343 [patent_doc_number] => 20100069289 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-18 [patent_title] => 'ANIMAL FEEDS AND VETERINARY COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 12/514425 [patent_app_country] => US [patent_app_date] => 2007-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11195 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20100069289.pdf [firstpage_image] =>[orig_patent_app_number] => 12514425 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 53169 [patent_doc_number] => 07772180 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-10 [patent_title] => 'Hepatitis C virus inhibitors' [patent_app_type] => utility [patent_app_number] => 11/934840 [patent_app_country] => US [patent_app_date] => 2007-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 80872 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/772/07772180.pdf [firstpage_image] =>[orig_patent_app_number] => 11934840 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5968966 [patent_doc_number] => 20110150835 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'Macrocyclic Inhibitors of Hepatitis C Virus NS3 Serine Protease' [patent_app_type] => utility [patent_app_number] => 11/931408 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49992 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0150/20110150835.pdf [firstpage_image] =>[orig_patent_app_number] => 11931408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4904504 [patent_doc_number] => 20080113918 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'AGONIST POLYPEPTIDE OF RECEPTOR FOR ZOT AND ZONULIN' [patent_app_type] => utility [patent_app_number] => 11/933132 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10067 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20080113918.pdf [firstpage_image] =>[orig_patent_app_number] => 11933132 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5576204 [patent_doc_number] => 20090143566 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'Growth Factor Analogs' [patent_app_type] => utility [patent_app_number] => 11/927118 [patent_app_country] => US [patent_app_date] => 2007-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12744 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20090143566.pdf [firstpage_image] =>[orig_patent_app_number] => 11927118 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6575598 [patent_doc_number] => 20100047179 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'TARGETED SPLIT BIOMOLECULAR CONJUGATES FOR THE TREATMENT OF DISEASES, MALIGNANCIES AND DISORDERS, AND METHODS OF THEIR PRODUCTION' [patent_app_type] => utility [patent_app_number] => 12/447368 [patent_app_country] => US [patent_app_date] => 2007-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 29449 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20100047179.pdf [firstpage_image] =>[orig_patent_app_number] => 12447368 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8664413 [patent_doc_number] => 08377874 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-19 [patent_title] => 'HCV NS3 protease inhibitors' [patent_app_type] => utility [patent_app_number] => 12/446789 [patent_app_country] => US [patent_app_date] => 2007-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25312 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12446789 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8664412 [patent_doc_number] => 08377873 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-19 [patent_title] => 'HCV NS3 protease inhibitors' [patent_app_type] => utility [patent_app_number] => 12/446296 [patent_app_country] => US [patent_app_date] => 2007-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13217 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12446296 [rel_patent_id] =>[rel_patent_doc_number] =>)